American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease

AGA Institute Clinical Practice and Quality Management Committee; Jonathan P Terdiman; Claudia B Gruss; Joel J Heidelbaugh; Shahnaz Sultan; Yngve T Falck-Ytter; David S. Weinberg

doi:10.1053/j.gastro.2013.10.047

American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease

AGA Institute Clinical Practice and Quality Management Committee
, Jonathan P Terdiman
, Claudia B Gruss
, Joel J Heidelbaugh
, Shahnaz Sultan
, Yngve T Falck-Ytter
, David S. Weinberg

University of California

Research output: Contribution to journal › Article › peer-review

210 Scopus citations

Original language	English
Pages (from-to)	1459-1463
Number of pages	5
Journal	Gastroenterology
Volume	145
Issue number	6
DOIs	https://doi.org/10.1053/j.gastro.2013.10.047
State	Published - Dec 2013

Keywords

Azathioprine/therapeutic use
Crohn Disease/drug therapy
Gastroenterology
Humans
Mercaptopurine/therapeutic use
Methotrexate/therapeutic use
Remission Induction
Societies, Medical
Tumor Necrosis Factor-alpha/antagonists & inhibitors
United States

Access to Document

10.1053/j.gastro.2013.10.047

Fingerprint

Dive into the research topics of 'American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease'. Together they form a unique fingerprint.

Cite this

AGA Institute Clinical Practice and Quality Management Committee, Terdiman, J. P., Gruss, C. B., Heidelbaugh, J. J., Sultan, S., Falck-Ytter, Y. T., & Weinberg, D. S. (2013). American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology, 145(6), 1459-1463. https://doi.org/10.1053/j.gastro.2013.10.047

AGA Institute Clinical Practice and Quality Management Committee ; Terdiman, Jonathan P ; Gruss, Claudia B et al. / American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. In: Gastroenterology. 2013 ; Vol. 145, No. 6. pp. 1459-1463.

@article{9e4d173d42be45d9b42b38e667de555b,

title = "American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease",

keywords = "Azathioprine/therapeutic use, Crohn Disease/drug therapy, Gastroenterology, Humans, Mercaptopurine/therapeutic use, Methotrexate/therapeutic use, Remission Induction, Societies, Medical, Tumor Necrosis Factor-alpha/antagonists \& inhibitors, United States",

author = "\{AGA Institute Clinical Practice and Quality Management Committee\} and Terdiman, \{Jonathan P\} and Gruss, \{Claudia B\} and Heidelbaugh, \{Joel J\} and Shahnaz Sultan and Falck-Ytter, \{Yngve T\} and Weinberg, \{David S.\}",

year = "2013",

month = dec,

doi = "10.1053/j.gastro.2013.10.047",

language = "English",

volume = "145",

pages = "1459--1463",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders",

number = "6",

}

AGA Institute Clinical Practice and Quality Management Committee, Terdiman, JP, Gruss, CB, Heidelbaugh, JJ, Sultan, S, Falck-Ytter, YT & Weinberg, DS 2013, 'American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease', Gastroenterology, vol. 145, no. 6, pp. 1459-1463. https://doi.org/10.1053/j.gastro.2013.10.047

American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. / AGA Institute Clinical Practice and Quality Management Committee; Terdiman, Jonathan P; Gruss, Claudia B et al.
In: Gastroenterology, Vol. 145, No. 6, 12.2013, p. 1459-1463.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease

AU - AGA Institute Clinical Practice and Quality Management Committee

AU - Terdiman, Jonathan P

AU - Gruss, Claudia B

AU - Heidelbaugh, Joel J

AU - Sultan, Shahnaz

AU - Falck-Ytter, Yngve T

AU - Weinberg, David S.

PY - 2013/12

Y1 - 2013/12

KW - Azathioprine/therapeutic use

KW - Crohn Disease/drug therapy

KW - Gastroenterology

KW - Humans

KW - Mercaptopurine/therapeutic use

KW - Methotrexate/therapeutic use

KW - Remission Induction

KW - Societies, Medical

KW - Tumor Necrosis Factor-alpha/antagonists & inhibitors

KW - United States

UR - https://www.scopus.com/pages/publications/84888221077

U2 - 10.1053/j.gastro.2013.10.047

DO - 10.1053/j.gastro.2013.10.047

M3 - Article

C2 - 24267474

SN - 0016-5085

VL - 145

SP - 1459

EP - 1463

JO - Gastroenterology

JF - Gastroenterology

IS - 6

ER -

AGA Institute Clinical Practice and Quality Management Committee, Terdiman JP, Gruss CB, Heidelbaugh JJ, Sultan S, Falck-Ytter YT et al. American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology. 2013 Dec;145(6):1459-1463. doi: 10.1053/j.gastro.2013.10.047

American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease

Keywords

Access to Document

Other files and links

Fingerprint

Cite this